exemestane
Showing 26 - 50 of 158
Metastatic Breast Cancer Trial in Chuo-ku, Nihonbashi, Koami-cho (Paclitaxel, Bevacizumab, Letrozole)
Completed
- Metastatic Breast Cancer
- Paclitaxel
- +7 more
-
Chuo-ku, Nihonbashi, Koami-cho, Tokyo, JapanJapan Breast Cancer Research Group
Aug 2, 2022
Breast Cancer Trial in Baltimore (Tamoxifen Citrate, Letrozole, Exemestane)
Recruiting
- Breast Cancer
- Tamoxifen Citrate
- +4 more
-
Baltimore, MarylandJohns Hopkins Bayview Hospital
Nov 30, 2021
Breast Cancer Trial in Worldwide (ribociclib (LEE011), Exemestane, Everolimus (RAD001))
Completed
- Breast Cancer
- ribociclib (LEE011)
- +2 more
-
Fayetteville, Arkansas
- +12 more
Apr 8, 2021
Breast Cancer Metastatic Trial in Ravensburg (Ribociclib, Anastrozole, Letrozole)
Active, not recruiting
- Breast Cancer Metastatic
- Ribociclib
- +4 more
-
Ravensburg, GermanyStudienzentrum Onkologie Ravensburg
Mar 7, 2022
Solid Tumors and Lymphomas Trial in United States (Alobresib, Exemestane, Fulvestrant)
Sequence in HR+, HER2 - mBC in Moscow: A Multicenter
Recruiting
- Breast Cancer Stage IV
- Palbociclib
- +8 more
-
Moscow, Russian FederationN.N. Blokhin National Medical Research Center of Oncology
Apr 15, 2021
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative Trial in United States (Anastrozole,
Active, not recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +6 more
- Anastrozole
- +6 more
-
Atlanta, Georgia
- +9 more
Oct 12, 2022
Breast Cancer, Invasive Breast Cancer Trial in Milwaukee (Anastrozole, Letrozole, Exemestane)
Active, not recruiting
- Breast Cancer
- Invasive Breast Cancer
- Anastrozole
- +3 more
-
Milwaukee, WisconsinFroedtert Hospital
Sep 16, 2021
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8
Recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +13 more
- Anastrozole
- +9 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jan 6, 2023
Breast Cancer Trial in Guangzhou (Tucidinostat, Exemestane, Ovarian function suppression)
Unknown status
- Breast Cancer
- Tucidinostat
- +2 more
-
Guangzhou, Guangdong, ChinaThe first affiliated hospital of Sun Yat-Sen university
Jul 22, 2020
Metastatic Breast Cancer Trial in Houston (Exemestane, Sutent)
Terminated
- Metastatic Breast Cancer
- Exemestane
- Sutent
-
Houston, TexasBaylor College of Medicine, Lester and Sue Smith Breast Center
Jul 9, 2020
ER+ Breast Cancer, HER2-negative Breast Cancer Trial in Christchurch, London, Oxford (Palbociclib 125Mg Tab, Fulvestrant
Recruiting
- ER+ Breast Cancer
- HER2-negative Breast Cancer
- Palbociclib 125Mg Tab
- +5 more
-
Christchurch, United Kingdom
- +3 more
May 19, 2022
Advanced or Recurrent Breast Cancer Trial in Japan (Entinostat, Entinostat(Placebo), Exemestane)
Completed
- Advanced or Recurrent Breast Cancer
- Entinostat
- +2 more
-
Nagoya, Aichi, Japan
- +27 more
Jun 15, 2022
Breast Cancer Trial in Houston (Everolimus, Exemestane, Metformin)
Terminated
- Breast Cancer
- Everolimus
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 5, 2020
Breast Tumor Trial in Mainz (Palbociclib, Fulvestrant, Anastrozole)
Terminated
- Breast Neoplasm
- Palbociclib
- +4 more
-
Mainz, GermanyUniversity Hospital Mainz
Dec 16, 2021
Breast Cancer Trial in Worldwide (Enzalutamide, exemestane, Placebo (for enzalutamide))
Breast Cancer Trial in Belgium, France, United States (Sapanisertib, Fulvestrant, Exemestane)
Estrogen-receptor Positive Invasive Metastatic Breast Cancer Trial in Philadelphia (Ruxolitinib, Exemestane)
Completed
- Estrogen-receptor Positive Invasive Metastatic Breast Cancer
- Ruxolitinib
- Exemestane
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Apr 29, 2020
Metastatic Beast Cancer Trial in New York (Exemestane, Cyclophosphamide)
Completed
- Metastatic Beast Cancer
- Exemestane
- Cyclophosphamide
-
New York, New YorkNYU Cancer Center
Mar 3, 2020